{
  "guideline": {
    "id": "PA166114461",
    "name": "Annotation of CPIC Guideline for ivacaftor and CFTR",
    "source": "CPIC",
    "version": 61,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166114461",
    "relatedChemicals": [
      {
        "id": "PA165950341",
        "name": "ivacaftor",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA109",
        "name": "cystic fibrosis transmembrane conductance regulator",
        "symbol": "CFTR"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166298188",
      "name": "Recommendation PA166298188",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA165950341",
          "name": "ivacaftor",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060790,
        "html": "<p>Use ivacaftor according to the product label</p>\n"
      },
      "implications": [
        "CFTR: An individual diagnosed with cystic fibrosis (CF) and CFTR variants listed in the FDA-approved drug label as being responsive to ivacaftor"
      ],
      "lookupKey": {
        "CFTR": "ivacaftor responsive in CF patients"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298187",
      "name": "Recommendation PA166298187",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA165950341",
          "name": "ivacaftor",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060789,
        "html": "<p>Ivacaftor is not recommended</p>\n"
      },
      "implications": [
        "CFTR: An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor."
      ],
      "lookupKey": {
        "CFTR": "ivacaftor non-responsive in CF patients"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "24598717",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.",
      "authors": [
        "Clancy J P",
        "Johnson S G",
        "Yee S W",
        "McDonagh E M",
        "Caudle K E",
        "Klein T E",
        "Cannavo M",
        "Giacomini K M",
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2014
    }
  ],
  "version": "2023-12-19-10-38"
}